Content Summary
Ron Cisliek, Director of Business Development – USA, all of IGS GeboJagema,
discuss the value of bringing an industrialisation partner on board early in
product development and how working with a single manufacturing specialist
can preserve insights and learnings throughout the product development lifecycle
and deliver additional value and quality.
Access this content
Choose an option below
Your content has been opened.
Register to access this content
Verify your email to access this content
Code sent. Enter it in the modal
Your content has been opened.
Why do I need to verify I’m human?
Please verify you are a human before opening this content.
Your content has been opened.
The content will open in a new window. You may need to allow popups for this site.
Check your inbox
Streamlining drug delivery device development for industrialisation success has been emailed to . Entered the wrong email?
Don't see the content in your inbox?
Make sure to check your spam and other messages folders.
Can't get to your email right now?
By accessing content on the Plastics News Online Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.
You might also be interested in
BC PARTNERS TO INVEST IN IGS GEBOJAGEMA IN PARTNERSHIP WITH MANAGEMENT AND SMILE INVEST
June 4 2025 – IGS GeboJagema (“IGS”) (www.igsgebojagema.nl), the leading independent pure-play healthcare manufacturer in the tooling market, announces, together with its current...
Read More
The Servitisation Revolution
A fundamental change in the relationship between manufacturers and customers.
Read More
IGS Article: Implementing Industry 4.0: Lessons learned over two decades.
In this piece, Herman Rusch, Chief Executive Officer, and Rob van den Brand, Chief Operating Officer, both of IGS GeboJagema, present four lessons for implementing Industry 4.0...
Read More
